Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum (Q27851722)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum |
scientific article |
Statements
1 reference
Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum (English)
1 reference
13 March 2012
0 references
106
0 references
6
0 references
1039-44
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference